Vincerx Pharma, Inc.

VINC

Vincerx Pharma, Inc.

VINC

Insider Sentiment (TTM):

Last Purchase:2023-08-11Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-06-30Institutional Shares Owned:50Shares Outstanding:3,580,000Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2025-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30
Assets
Cash	-	-	-	-	-	-	-	-	-	-	-	81
Cash And Cash Equivalents At Carrying Value	4	5	3	8	5	13	15	7	4	12	46	-
Restricted Cash Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	5	6	12	18	8	15	23	32	44	56	67	82
Marketable Securities Current	-	-	7	8	-	0	6	21	35	41	20	-
Prepaid Expense Current	0	0	0	1	1	0	0	1	1	0	0	1
Grants Receivable Current	0	1	1	1	1	1	1	1	-	1	-	-
Other Assets Current	0	0	0	0	1	1	1	2	3	2	1	1
Operating Lease Right Of Use Asset	-	0	1	2	2	2	2	3	3	3	3	4
Property Plant And Equipment Net	-	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	-	2	0	0	0	1	1	1	0	0	2	2
Grants Receivable Noncurrent	0	-	2	1	1	-	-	-	-	-	-	-
Assets	5	8	15	22	11	18	26	35	47	59	72	88
Liabilities And Stockhold…
Accounts Payable Current	2	2	2	2	2	2	3	4	6	4	4	5
Liabilities Current
Liabilities Current	3	5	5	5	11	6	9	9	11	9	10	10
Accrued Liabilities Current	0	3	2	2	2	2	5	4	3	4	4	4
Operating Lease Liability Current	-	0	1	1	1	1	1	1	1	1	1	1
Derivative Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Operating Lease Liability Noncurrent	-	0	0	1	1	1	2	2	2	2	3	3
Other Liabilities Noncurrent	-	0	0	0	0	0	0	0	0	0	0	-
Liabilities	3	5	6	6	12	7	11	11	13	12	13	13
Stockholders Equity Inclu…
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	196	192	190	189	171	170	172	171	170	167	167	165
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	-0	-0	0
Retained Earnings Accumulated Deficit	-194	-189	-181	-173	-172	-159	-157	-147	-136	-119	-108	-91
Stockholders Equity	2	3	9	15	-1	11	16	24	34	48	60	74
Liabilities And Stockholders Equity	5	8	15	22	11	18	26	35	47	59	72	88
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	30	30	30	30	30	30	30	30	30	30	30	30
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	5	2	2	1	1	1	1	1	1	1	1	1
Shares Outstanding	5	2	2	1	1	1	1	1	1	1	1	1
Stockholders Equity Note Stock Split Conversion Ra…	-	0	-	-	-	-	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	14.00%	-24.00%	-28.00%	-	-	-	-	-	-	-	-	-
2024	-6.93%	-1.96%	-21.57%	47.48%	23.20%	-31.65%	-39.82%	-31.86%	-76.70%	-51.50%	-90.30%	-90.30%
2023	12.65%	-21.69%	-36.14%	-19.09%	14.77%	2.27%	-18.75%	47.50%	52.50%	-	-	-
2022	-	-	-	-2.70%	-6.76%	-27.70%	-22.58%	9.68%	37.63%	0.00%	66.32%	56.84%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30
Liquidity Ratios
Current Ratio	1.79	1.21	2.17	3.43	0.72	2.63	2.58	3.47	4.11	6.11	6.76	7.88
Quick Ratio	1.74	1.20	2.11	3.33	0.66	2.62	2.54	3.40	4.03	6.10	6.71	7.80
Working Capital	2.07M	1.13M	6.32M	12.95M	-2.96M	9.13M	13.97M	22.66M	33.30M	46.81M	57.31M	71.94M
Leverage & Debt
Debt to Equity	1.27	1.94	0.64	0.39	-18.82	0.62	0.67	0.46	0.38	0.24	0.21	0.18
Interest Coverage TTM	-	-	-	-	-	-	-	-	-8,121.50	-4,449.44	-4,741.13	-4,805.50
Debt Ratio	0.56	0.66	0.39	0.28	1.06	0.38	0.40	0.32	0.27	0.20	0.18	0.15
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-6.33	-15.85	-11.84	-14.71	-34.96	-37.71	-43.54	-51.08	-57.78	-59.90	-55.21	-62.72
Free Cash Flow Per Share TTM	-6.38	-13.77	-12.25	-14.73	-32.35	-37.98	-43.34	-51.22	-54.43	-56.69	-54.34	-50.24
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-40.31%	-25.11%	-41.83%	-48.11%	-38.02%	-36.24%	-20.15%	-17.47%	23.77%	60.24%	78.28%	681.45%
EPS Growth (1Y)	-81.91%	-57.98%	-72.81%	-71.21%	-39.49%	-37.05%	-21.13%	-18.55%	22.07%	30.88%	49.62%	508.56%
Valuation Metrics
P/E TTM	-0.08	-0.33	-1.21	-1.10	-2.89	-0.63	-0.46	-0.51	-0.36	-0.34	-0.50	-0.42
P/B TTM	0.92	3.67	3.59	2.01	-176.53	2.24	1.37	1.15	0.64	0.45	0.49	0.37
Market Cap	1.89M	9.98M	32.70M	31.05M	109.80M	25.13M	21.56M	27.66M	22.04M	21.45M	29.09M	27.71M
Enterprise Value	-2.63M	4.92M	29.67M	23.05M	104.61M	12.28M	6.41M	20.91M	17.48M	9.72M	-16.77M	-53.21M
Calculated Values
Free Cash Flow TTM	-22.84M	-26.13M	-27.97M	-28.23M	-35.10M	-40.45M	-46.25M	-54.48M	-57.67M	-59.60M	-57.28M	-52.74M
Net Debt	-4.52M	-5.07M	-3.03M	-8.01M	-5.19M	-12.85M	-15.15M	-6.75M	-4.56M	-11.73M	-45.87M	-80.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-08-11Purchase

Owner: Seelenberger, Alexander A…

Title: See Remarks

Shares: 10,500

Price/Share: $0.95

Value: $9,975.00

Shares Owned: 30,280

Relationship: Officer

Ownership: Direct

2023-08-10Purchase

Owner: Thomas, Tom C

Title: See Remarks

Shares: 5,000

Price/Share: $0.95

Value: $4,750.00

Shares Owned: 219,935

Relationship: Officer

Ownership: Direct

2023-08-10Purchase

Owner: Izumi, Raquel E.

Title: See Remarks

Shares: 3,440

Price/Share: $0.93

Value: $3,199.20

Shares Owned: 85,214

Relationship: Director,Officer

Ownership: Indirect

2023-08-10Purchase

Owner: Hamdy, Ahmed Md

Title: See Remarks

Shares: 5,400

Price/Share: $0.96

Value: $5,184.00

Shares Owned: 96,060

Relationship: Director,Officer

Ownership: Indirect

2022-12-14Purchase

Owner: Hamdy, Ahmed Md

Title: Chief Executive Officer

Shares: 35,280

Price/Share: $0.87

Value: $30,693.60

Shares Owned: 73,760

Relationship: Director,Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-08-11	Seelenberger, Alexander A…	Officer	See Remarks	Direct	Purchase	10,500	0.95	$9,975.00	30,280	4
2023-08-10	Thomas, Tom C	Officer	See Remarks	Direct	Purchase	5,000	0.95	$4,750.00	219,935	4
2023-08-10	Izumi, Raquel E.	Director,Officer	See Remarks	Indirect	Purchase	3,440	0.93	$3,199.20	85,214	4
2023-08-10	Hamdy, Ahmed Md	Director,Officer	See Remarks	Indirect	Purchase	5,400	0.96	$5,184.00	96,060	4
2022-12-14	Hamdy, Ahmed Md	Director,Officer	Chief Executive Officer	Indirect	Purchase	35,280	0.87	$30,693.60	73,760	4
2022-12-14	Izumi, Raquel E.	Director,Officer	See Remarks	Indirect	Purchase	28,738	0.88	$25,289.44	68,738	4
2022-12-14	Thomas, Tom C	Officer	See Remarks	Indirect	Purchase	7,000	0.83	$5,810.00	10,000	4
2022-08-25	Lowe, Christopher P.	Director	-	Direct	Purchase	11,600	1.65	$19,140.00	40,000	4
2022-06-27	Izumi, Raquel E.	Director,Officer	See Remarks	Indirect	Purchase	40,000	1.41	$56,400.00	40,000	4
2022-06-23	Hamdy, Ahmed Md	Director,Officer	Chief Executive Officer	Indirect	Purchase	24,200	1.41	$34,122.00	38,480	4
2022-06-09	Bushnell, Laura I.	Director	-	Direct	Purchase	15,000	1.91	$28,650.00	19,202	4
2021-12-23	Hwang, Sooin	Officer	Chief Business Officer	Direct	Purchase	3,000	10.00	$30,000.00	390,491	4
2021-12-22	Hamdy, Ahmed Md	Director,Officer	Chief Executive Officer	Indirect	Purchase	6,450	10.02	$64,629.00	14,280	4
2021-12-22	Seelenberger, Alexander A…	Officer	Chief Financial Officer	Direct	Purchase	2,417	10.34	$24,991.78	12,493	4
2021-12-22	Bushnell, Laura I.	Director	-	Direct	Purchase	2,402	10.48	$25,172.96	4,202	4
2021-12-22	Thomas, Tom C	Officer	See Remarks	Indirect	Purchase	1,000	10.23	$10,230.00	3,000	4
2021-08-04	Izumi, Raquel E.	Director,Officer	See Remarks	Indirect	Purchase	1,000	11.96	$11,960.00	1,000	4
2021-06-30	Lowe, Christopher P.	Director	-	Direct	Purchase	3,600	12.66	$45,576.00	10,000	4
2021-06-30	Hwang, Sooin	Officer	Chief Business Officer	Direct	Purchase	500	12.66	$6,330.00	385,575	4
2021-06-30	Bushnell, Laura I.	Director	-	Direct	Purchase	1,800	12.94	$23,292.00	1,800	4
2021-06-29	Thomas, Tom C	Officer	See Remarks	Indirect	Purchase	2,000	12.58	$25,160.00	2,000	4
2021-06-29	Mcdonald, Andrew I	Director	-	Direct	Purchase	20,000	12.38	$247,600.00	20,000	4
2021-06-29	Lee, John H.	Director	-	Direct	Purchase	799	12.72	$10,163.28	799	4
2021-06-29	Hamdy, Ahmed Md	Director,Officer	Chief Executive Officer	Indirect	Purchase	7,830	12.77	$99,989.10	7,830	4
2021-06-29	Seelenberger, Alexander A…	Officer	Chief Financial Officer	Direct	Purchase	7,950	12.61	$100,249.50	7,950	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-06-30

0.00%

Inst. Shares: 50

Shares Outstanding: 3,580,000

2025-03-31

6.16%

Inst. Shares: 220,626

Shares Outstanding: 3,580,000

2024-12-31

249.65%

Inst. Shares: 4,738,441

Shares Outstanding: 1,898,000

2024-09-30

Inst. Shares: 10,460,559

Shares Outstanding: 2,283,600

2024-06-30

Inst. Shares: 10,205,823

Shares Outstanding: 1,916,950

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-06-30	50	3,580,000	0.00%
2025-03-31	220,626	3,580,000	6.16%
2024-12-31	4,738,441	1,898,000	249.65%
2024-09-30	10,460,559	2,283,600	-
2024-06-30	10,205,823	1,916,950	-
2024-03-31	7,973,631	1,085,000	-
2023-12-31	9,204,132	1,065,000	-
2023-09-30	10,086,319	1,067,250	-
2023-06-30	11,430,986	1,063,700	-
2023-03-31	11,208,174	1,059,400	-
2022-12-31	12,078,470	1,051,450	-
2022-09-30	14,525,788	1,054,150	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Vincerx Pharma, Inc. (VINC) — SEC Financial Statements & Analysis

Vincerx Pharma, Inc. (VINC) is a pharmaceutical preparations company. Vincerx Pharma, Inc. trades on None as: VINC. Based on its latest SEC filing (Form 10-Q, period ending 2025-03-31), Vincerx Pharma, Inc. reported a Debt-to-Equity ratio of 1.27x, a Price-to-Book (P/B) ratio of 0.92x (TTM), at a market cap of $1.89M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 1.27x
P/B TTM: 0.92x
Market Cap: $1.89M

Data as of 2025-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Vincerx Pharma, Inc. in?

Vincerx Pharma, Inc. (VINC) operates in the Pharmaceutical Preparations industry.

What is VINC's market cap?

Vincerx Pharma, Inc. (VINC) has a market capitalization of $1.89M as of 2025-03-31.

What exchange does VINC trade on?

Vincerx Pharma, Inc. (VINC) trades on the None.